Proximal splenic artery embolization using a vascular plug in grade IV or V splenic trauma - a single centre 11-year experience.

Samuel S Xu, Kevin Eng, Fabio Accorsi, Derek W Cool, Daniele Wiseman, Amol Mujoomdar, Leandro Cardarelli-Leite

Abstract read

In one paragraph

Article in CVIR endovascular, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Comparative Analysis of the LOBO Device and Coils for Proximal Splenic Artery Embolization: A Multi-Institutional Retrospective Study.Cardiovascular and interventional radiology · 2026
Article
Clinical analysis on comparison of outcomes between partial splenic artery embolization and splenectomy for management of grade II-III splenic injury in blunt trauma.European journal of medical research · 2025
Article
Preventive Proximal Splenic Artery Embolization for High-Grade AAST-OIS Adult Spleen Trauma without Vascular Anomaly on the Initial CT Scan: Technical Aspect, Safety, and Efficacy-An Ancillary Study.Journal of personalized medicine · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samuel S XuUniversity of Western Ontario, London, Ontario, Canada. sam.sh.xu@gmail.com.ORCID http://orcid.org/0000-0001-7698-1501

Kevin EngUniversity of Western Ontario, London, Ontario, Canada.ORCID https://orcid.org/0000-0001-6511-0567

Fabio AccorsiUniversity of Western Ontario, London, Ontario, Canada.ORCID https://orcid.org/0000-0002-1566-1368

Derek W CoolUniversity of Western Ontario, London, Ontario, Canada.ORCID https://orcid.org/0000-0003-1095-3553

Daniele WisemanUniversity of Western Ontario, London, Ontario, Canada.ORCID https://orcid.org/0000-0002-9370-4159

Amol MujoomdarUniversity of Western Ontario, London, Ontario, Canada.ORCID https://orcid.org/0000-0002-4012-6068

Leandro Cardarelli-LeiteUniversity of Western Ontario, London, Ontario, Canada.ORCID https://orcid.org/0000-0003-1653-3760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36627472

DOI10.1186/s42155-022-00345-8

PMCPMC9832195

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.